Statistics for Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial
Total visits
| views | |
|---|---|
| Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial | 68 |
Total visits per month
| views | |
|---|---|
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
File Visits
| views | |
|---|---|
| 1-s2.0-S2589537020302613-main Safety and immunogenicity evaluation of recombinant BCG vaccine.pdf | 3 |
Top country views
| views | |
|---|---|
| United States | 43 |
| Chile | 9 |
| France | 4 |
| Israel | 3 |
| Sweden | 2 |
| Mexico | 1 |
Top city views
| views | |
|---|---|
| Miami | 36 |
| Santiago | 7 |
| Alameda | 5 |
| Tel Aviv | 2 |
| Campbell | 1 |
| Lolol | 1 |
| Puerto Montt | 1 |
| Sacramento | 1 |
| Stockholm | 1 |
| Zapopan | 1 |
| Åkersberga | 1 |